The United Laboratories

The United Laboratories (Stock Code: 3933.HK) was founded in Hong Kong in 1990. It currently owns six production entities: The United Laboratories Factory Limited (Hong Kong), The United Laboratories International Holdings Ltd, Zhongshan Branch of The United Laboratories International Holdings Ltd, Guangdong Kaiping Jinyi Capsules Co., Ltd., The United Laboratories (Inner Mongolia) Co., Ltd., and Inner Mongolia United Animal Health Pharmaceutical Co., Ltd. It also has a professional R&D center for chemical medicines and biologics. Its product range covers pharmaceutical intermediates, active pharmaceutical ingredients, and formulations, with approximately 12,000 employees in total. It is a comprehensive pharmaceutical group integrating R&D, production, and operations. All workshops of The United Laboratories have passed the new version of China’s GMP certification, and multiple products have successively obtained EU GMP certification and U.S. FDA certification. With advanced enzymatic production technology, The United Laboratories became the first company in China to obtain the EU CEP certificate for enzymatic amoxicillin, and several scientific and technological achievements have been granted national patents.